Structures by: Filali M.
Total: 3
Methyl 4-[3,6-bis(pyridin-2-yl)pyridazin-4-yl]benzoate
C22H16N4O2
Acta Crystallographica Section E (2019) 75, 11 1672-1678
a=6.04640(10)Å b=11.7175(3)Å c=13.2931(3)Å
α=95.7350(10)° β=95.8130(10)° γ=101.7800(10)°
4-[(Prop-2-en-1-yloxy)methyl]-3,6-bis(pyridin-2-yl)pyridazine
C18H16N4O
Acta Crystallographica Section E (2019) 75, 9 1321-1326
a=8.9420(2)Å b=15.1130(3)Å c=11.5829(3)Å
α=90° β=100.1320(10)° γ=90°
3,6-Bis(pyridin-2-yl)-4-{[(3a<i>S</i>,5<i>S</i>,5a<i>R</i>,8a<i>R</i>,8b<i>S</i>)-2,2,7,7-tetramethyltetrahydro-5<i>H</i>-bis[1,3]dioxolo[4,5-<i>b</i>:4',5'-<i>d</i>]pyran-5-yl)methoxy]methyl}pyridazine monohydrate
C27H30N4O6,H2O
Acta Crystallographica Section E (2019) 75, 8 1169-1174
a=8.8417(3)Å b=11.3252(3)Å c=25.7003(8)Å
α=90° β=90° γ=90°